Over the past decade, several urinary and blood biomarkers have been postulated for the early detection of AKI, including neutrophil gelatinase associated lipocalin (NGAL), kidney injury marker 1 (KIM-1) and interleukin-18 (IL-18), with inherent limitations [5, 6]. This evidence concerns the gene IL18 and acute kidney injury.